A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
Clinical trial NCT02095119 · COMPLETED
Trial details
- NCT number
- NCT02095119
- Sponsor
- National Institute of Cancerología
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2013-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.